Sensus Healthcare, Inc.(SRTS)Earnings, Financials & Key Ratios

SRTS•NASDAQ

$4.09

$67M mkt cap·10.0× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryImaging, radiation, and oncology devices

AboutSensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.Show more

Revenue$42M+71.3%
EBITDA$9M+10687.3%
Net Income$7M+1270.5%
EPS (Diluted)0.41+1275.8%
Gross Margin58.44%+1.4%
EBITDA Margin20.38%+6197.2%
Operating Margin19.35%+1336.2%
Net Margin15.9%+700.0%
ROE12.7%+1169.0%
ROIC19.94%+1841.9%
Debt/Equity0.01-32.7%

Technical→

SRTS Key Insights

Sensus Healthcare, Inc. (SRTS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 26.4%
✓Trading at only 1.2x book value

✗Weaknesses

✗Negative free cash flow
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SRTS Price & Volume

Sensus Healthcare, Inc. (SRTS) stock price & volume — 10-year historical chart

Loading chart...

SRTS Growth Metrics

Sensus Healthcare, Inc. (SRTS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years21.82%

5 Years8.93%

3 Years15.63%

TTM-13.79%

Profit CAGR

10 Years-

5 Years-

3 Years17.29%

TTM-132.28%

EPS CAGR

10 Years-

5 Years-

3 Years17.93%

TTM-132.69%

Return on Capital

10 Years-1.25%

5 Years7.97%

3 Years17.97%

Last Year15.3%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
XTLBXTL Biopharmaceuticals Ltd.Direct Competitor	357.58K	3.25	-0.34		-227.72%	-25.53%	0.03
STXSStereotaxis, Inc.Direct Competitor	179.18M	1.92	-6.40	0.55%	-78.56%	-249.4%	0.53
ARAYAccuray IncorporatedDirect Competitor	58.45M	0.49	-31.75	2.68%	-10.76%	-77.48%	2.17
ISRGIntuitive Surgical, Inc.Product Competitor	160.44B	451.73	57.40	20.51%	28.15%	16.89%	0.02
GKOSGlaukos CorporationProduct Competitor	7.92B	135.27	-41.24	32.33%	-34.34%	-26.46%	0.21
NVCRNovoCure LimitedProduct Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
EWEdwards Lifesciences CorporationSupply Chain	47.97B	83.20	45.46	11.55%	17.64%	10.35%	0.07
MDTMedtronic plcSupply Chain	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59

Compare SRTS vs Peers

Sensus Healthcare, Inc. (SRTS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XTLB

Most directly comparable listed peer for SRTS.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare SRTS against a more recognizable public peer.

Peer Set

Compare Top 5

vs XTLB, STXS, ARAY, ISRG

SRTS Income Statement

Sensus Healthcare, Inc. (SRTS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Sales/Revenue	14.81M	20.59M	26.43M	27.26M	9.58M	27.04M	44.53M	24.41M	41.81M	35.61M
Revenue Growth %	44.17%	39%	28.36%	3.16%	-64.87%	182.36%	64.68%	-45.2%	71.31%	-13.79%
Cost of Goods Sold	4.97M	6.79M	9.52M	9.71M	4.33M	10.05M	14.9M	10.35M	17.38M	18.53M
COGS % of Revenue	33.52%	32.97%	36.01%	35.6%	45.19%	37.18%	33.47%	42.39%	41.56%	-
Gross Profit	9.85M▲ 0%	13.8M▲ 40.2%	16.91M▲ 22.5%	17.56M▲ 3.8%	5.25M▼ 70.1%	16.99M▲ 223.6%	29.63M▲ 74.4%	14.06M▼ 52.5%	24.43M▲ 73.8%	17.08M▲ 0%
Gross Margin %	66.48%	67.03%	63.99%	64.4%	54.81%	62.82%	66.53%	57.61%	58.44%	47.95%
Gross Profit Growth %	49.76%	40.16%	22.54%	3.82%	-70.1%	223.64%	74.41%	-52.54%	73.76%	-
Operating Expenses	10.21M	17.52M	18.92M	19.53M	13.48M	12.87M	14.8M	14.44M	16.34M	22.51M
OpEx % of Revenue	68.93%	85.09%	71.58%	71.62%	140.79%	47.59%	33.23%	59.18%	39.09%	-
Selling, General & Admin	8.38M	12.03M	12.66M	13.11M	9.32M	9.43M	11.34M	10.76M	12.13M	15.05M
SG&A % of Revenue	56.61%	58.42%	47.89%	48.08%	97.37%	34.88%	25.46%	44.11%	29%	-
Research & Development	1.82M	5.49M	6.26M	6.42M	4.16M	3.44M	3.46M	3.68M	4.22M	7.46M
R&D % of Revenue	12.32%	26.67%	23.69%	23.54%	43.42%	12.71%	7.77%	15.07%	10.08%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income	-363.12K▲ 0%	-3.72M▼ 923.8%	-2.01M▲ 46.1%	-1.97M▲ 1.8%	-8.23M▼ 318.3%	4.12M▲ 150.0%	14.83M▲ 260.0%	-382K▼ 102.6%	8.09M▲ 2217.8%	-5.43M▲ 0%
Operating Margin %	-2.45%	-18.06%	-7.59%	-7.22%	-85.98%	15.24%	33.3%	-1.57%	19.35%	-15.25%
Operating Income Growth %	-64.12%	-923.75%	46.06%	1.85%	-318.33%	150.04%	259.98%	-102.58%	2217.8%	-
EBITDA	-25.54K	-3.33M	-1.35M	-1.42M	-7.51M	4.73M	15.34M	79K	8.52M	-4.9M
EBITDA Margin %	-0.17%	-16.17%	-5.1%	-5.22%	-78.44%	17.5%	34.45%	0.32%	20.38%	-13.75%
EBITDA Growth %	-127.07%	-12938.55%	59.54%	-5.6%	-428.06%	163.01%	224.11%	-99.48%	10687.34%	-139.66%
D&A (Non-Cash Add-back)	337.58K	387.92K	658.25K	545.72K	722K	613K	509K	461K	432K	536K
EBIT	-324.58K	-3.64M	-1.87M	-1.7M	-6.82M	4.12M	14.83M	-382K	8.09M	-2.34M
Net Interest Income	16.67K	6.93K	-17.41K	268.29K	52K	1K	380K	992K	932K	964K
Interest Income	38.54K	75.81K	139.28K	268.29K	66K	2K	382K	992K	932K	964K
Interest Expense	21.87K	68.88K	156.69K	0	14K	1K	2K	0	0	0
Other Income/Expense	16.67K	6.93K	-17.41K	268.29K	1.4M	-1K	13.16M	1.03M	932K	757K
Pretax Income	-346.45K▲ 0%	-3.71M▼ 971.0%	-2.02M▲ 45.5%	-1.7M▲ 16.0%	-6.84M▼ 302.1%	4.12M▲ 160.3%	27.99M▲ 579.5%	652K▼ 97.7%	9.02M▲ 1283.7%	-1.74M▲ 0%
Pretax Margin %	-2.34%	-18.02%	-7.65%	-6.24%	-71.38%	15.23%	62.85%	2.67%	21.58%	-4.89%
Income Tax	0	0	0	0	0	0	3.75M	167K	2.38M	1.26M
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	13.38%	25.61%	26.32%	-72.46%
Net Income	-346.45K▲ 0%	-3.71M▼ 971.0%	-2.02M▲ 45.5%	-1.7M▲ 16.0%	-6.84M▼ 302.1%	4.12M▲ 160.3%	24.24M▲ 488.6%	485K▼ 98.0%	6.65M▲ 1270.5%	-3.01M▲ 0%
Net Margin %	-2.34%	-18.02%	-7.65%	-6.24%	-71.38%	15.23%	54.44%	1.99%	15.9%	-8.44%
Net Income Growth %	-46.02%	-971.02%	45.49%	15.96%	-302.12%	160.25%	488.59%	-98%	1270.52%	-132.28%
Net Income (Continuing)	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M	-3.01M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.03▲ 0%	-0.28▼ 872.2%	-0.14▲ 50.0%	-0.07▲ 49.2%	-0.42▼ 490.7%	0.25▲ 159.5%	1.46▲ 484.0%	0.03▼ 98.0%	0.41▲ 1275.8%	-0.18▲ 0%
EPS Growth %	-30.91%	-872.22%	50%	49.21%	-490.72%	159.52%	484%	-97.96%	1275.84%	-132.69%
EPS (Basic)	-0.03	-0.28	-0.14	-0.07	-0.42	0.25	1.47	0.03	0.41	-
Diluted Shares Outstanding	12.03M	13.24M	14.12M	16.23M	16.43M	16.5M	16.62M	16.27M	16.36M	16.33M
Basic Shares Outstanding	12.03M	13.24M	14.12M	16.23M	16.43M	16.48M	16.48M	16.26M	16.31M	16.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

SRTS Balance Sheet

Sensus Healthcare, Inc. (SRTS) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Total Current Assets	16.76M	17.89M	31.9M	34M	25.17M	31.25M	53.24M	49.53M	56.74M	50.2M
Cash & Short-Term Investments	11.5M	11.19M	15.38M	15.49M	14.91M	14.52M	25.52M	23.15M	22.06M	24.45M
Cash Only	5.04M	10.09M	12.48M	8.1M	14.91M	14.52M	25.52M	23.15M	22.06M	24.45M
Short-Term Investments	6.46M	1.1M	2.89M	7.39M	0	0	0	0	0	0
Accounts Receivable	3.1M	4.96M	13.15M	14.01M	3.78M	12.13M	17.3M	10.64M	19.73M	9.34M
Days Sales Outstanding	76.36	87.9	181.57	187.58	143.91	163.72	141.79	159.21	172.26	153
Inventory	1.25M	1.17M	1.63M	3M	4.43M	1.76M	3.5M	11.86M	10.1M	14.38M
Days Inventory Outstanding	92.25	62.99	62.47	112.71	373.35	63.86	85.74	418.49	212.1	246.94
Other Current Assets	0	0	0	0	0	268K	660K	888K	1.51M	2.04M
Total Non-Current Assets	2.19M	948.47K	1.35M	2.92M	2.84M	995K	3.49M	4.18M	5.43M	8.09M
Property, Plant & Equipment	433.41K	394.08K	891.03K	2.48M	2.43M	774K	1.24M	1.24M	2.58M	3.04M
Fixed Asset Turnover	34.17x	52.24x	29.66x	10.98x	3.94x	34.94x	35.94x	19.71x	16.22x	11.66x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	626.51K	530.12K	433.74K	337.35K	338K	146K	50K	0	0	0
Long-Term Investments	1.1M	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	24.27K	24.27K	24.27K	101.56K	69K	75K	492K	804K	652K	6.86M
Total Assets	18.95M▲ 0%	18.84M▼ 0.6%	33.25M▲ 76.5%	36.92M▲ 11.0%	28.01M▼ 24.1%	32.24M▲ 15.1%	56.73M▲ 76.0%	53.71M▼ 5.3%	62.16M▲ 15.7%	58.3M▲ 0%
Asset Turnover	0.78x	1.09x	0.79x	0.74x	0.34x	0.84x	0.78x	0.45x	0.67x	0.59x
Asset Growth %	96.62%	-0.59%	76.54%	11.05%	-24.14%	15.1%	75.98%	-5.33%	15.74%	19.44%
Total Current Liabilities	3.66M	7.08M	6.02M	6.47M	4.86M	5.96M	7.7M	4.21M	5.88M	6.8M
Accounts Payable	2.76M	4.07M	5.17M	0	0	4.06M	5.52M	2.79M	4.81M	5.62M
Days Payables Outstanding	203.06	218.74	198.15	-	-	147.32	135.21	98.54	101.06	105.51
Short-Term Debt	0	0	0	0	0	51K	0	0	0	0
Deferred Revenue (Current)	853.8K	652.24K	722.02K	1.19M	1.49M	1.17M	693K	657K	541K	1.62M
Other Current Liabilities	40.48K	146.72K	136.22K	4.97M	3.06M	508K	403K	538K	329K	927K
Current Ratio	4.58x	2.53x	5.30x	5.26x	5.18x	5.24x	6.92x	11.76x	9.64x	9.64x
Quick Ratio	4.24x	2.36x	5.03x	4.79x	4.27x	4.94x	6.46x	8.94x	7.93x	7.93x
Cash Conversion Cycle	-34.45	-67.85	45.89	-	-	80.26	92.32	479.15	283.3	294.42
Total Non-Current Liabilities	16.25K	73.08K	766.73K	2.45M	1.66M	262K	969K	656K	453K	298K
Long-Term Debt	0	2.21M	0	0	267K	0	0	0	0	277K
Capital Lease Obligations	0	0	0	1.12M	812K	0	830K	596K	398K	1.43M
Deferred Tax Liabilities	0	-4.43M	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	-277K
Total Liabilities	3.67M	7.15M	6.79M	8.92M	6.51M	6.22M	8.67M	4.87M	6.34M	7.1M
Total Debt	0	2.21M	0	1.43M	1.38M	225K	1.02M	783K	602K	534K
Net Debt	-5.04M	-7.87M	-12.48M	-6.68M	-13.53M	-14.29M	-24.5M	-22.36M	-21.45M	-23.92M
Debt / Equity	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x	0.01x
Debt / EBITDA	-	-	-	-	-	0.05x	0.07x	9.91x	0.07x	-0.11x
Net Debt / EBITDA	-	-	-	-	-	-3.02x	-1.60x	-283.10x	-2.52x	-2.52x
Interest Coverage	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-	-
Total Equity	15.27M▲ 0%	11.68M▼ 23.5%	26.46M▲ 126.5%	28M▲ 5.8%	21.5M▼ 23.2%	26.02M▲ 21.0%	48.07M▲ 84.8%	48.84M▲ 1.6%	55.83M▲ 14.3%	51.19M▲ 0%
Equity Growth %	157.94%	-23.53%	126.54%	5.83%	-23.23%	21.02%	84.77%	1.61%	14.3%	10.86%
Book Value per Share	1.27	0.88	1.87	1.72	1.31	1.58	2.89	3.00	3.41	3.14
Total Shareholders' Equity	15.27M	11.68M	26.46M	28M	21.5M	26.02M	48.07M	48.84M	55.83M	51.19M
Common Stock	135.46K	135.22K	161.46K	165.4K	166K	167K	169K	169K	169K	169K
Retained Earnings	-7.79M	-11.5M	-13.53M	-15.23M	-22.06M	-17.94M	6.3M	6.79M	13.43M	8.88M
Treasury Stock	0	-133.82K	-133.82K	-252.57K	-310K	-325K	-3.43M	-3.52M	-3.57M	-3.87M
Accumulated OCI	-587.17K	-514.13K	-858.01K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

SRTS Cash Flow Statement

Sensus Healthcare, Inc. (SRTS) cash flow — operating, investing & free cash flow history

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Cash from Operations	-851.02K	-3.06M	-8.56M	-2.11M	-434.18K	-286K	-1.41M	-2.15M	-831K	-831K
Operating CF Margin %	-5.75%	-14.85%	-32.41%	-7.73%	-4.53%	-1.06%	-3.17%	-8.79%	-1.99%	-
Operating CF Growth %	36.46%	-259.17%	-180.17%	75.4%	79.39%	34.13%	-393.71%	-51.91%	61.26%	-131.95%
Net Income	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M	-3.01M
Depreciation & Amortization	337.58K	387.92K	658.25K	545.72K	721.87K	613K	509K	461K	432K	535K
Stock-Based Compensation	726.38K	405.9K	982.62K	620.92K	0	415K	187K	328K	323K	268K
Deferred Taxes	0	0	0	0	0	0	-1.71M	-427K	-57K	-613K
Other Non-Cash Items	3.03M	428.95K	108.53K	728.91K	118.21K	705K	-11.71M	568K	378K	-1.61M
Working Capital Changes	-4.6M	-568.86K	-8.29M	-2.3M	5.56M	-6.14M	-12.92M	-3.56M	-8.55M	5.39M
Change in Receivables	-1.03M	-2.05M	-8.17M	-1.22M	10.25M	-8.43M	-5.31M	6.65M	-9.21M	7.58M
Change in Inventory	-3.32M	118.92K	-661.42K	-1.7M	-1.43M	2.73M	-3.19M	-8.58M	268K	-2.59M
Change in Payables	0	0	0	-676.56K	-2.3M	962K	799K	-2.73M	2.02M	1.65M
Cash from Investing	-7.85M	6.17M	-2.64M	-4.9M	7.03M	129K	14.84M	-187K	-276K	259K
Capital Expenditures	-286K	-287.59K	-854.83K	-400.59K	-358.55K	-128K	-159K	-229K	-276K	259K
CapEx % of Revenue	1.93%	1.4%	3.23%	1.47%	3.74%	0.47%	0.36%	0.94%	0.66%	-
Acquisitions	7.85M	0	2.64B	0	0	257K	15M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-7.85M	6.46M	-2.64B	0	0	0	0	42K	0	0
Cash from Financing	8.68M	1.93M	13.6M	2.62M	210.01K	-231K	-2.43M	-40K	15K	-272K
Debt Issued (Net)	-422.7K	2.21M	-2.21M	0	266.78K	-216K	-51K	0	0	0
Equity Issued (Net)	1000K	0	1000K	1000K	560	-15K	-1000K	-27K	67K	-267K
Dividends Paid	-2.55M	0	0	0	0	0	0	0	0	0
Share Repurchases	0	-289.29K	0	0	0	-15K	-3M	-27K	0	-300K
Other Financing	-994.02K	-289.29K	-1.43M	-118.75K	-57.33K	0	622K	-13K	-52K	-5K
Net Change in Cash	-22.59K▲ 0%	5.04M▲ 22423.0%	2.4M▼ 52.4%	-4.38M▼ 282.8%	6.81M▲ 255.3%	-388K▼ 105.7%	11M▲ 2935.3%	-2.37M▼ 121.6%	-1.09M▲ 54.0%	1.9M▲ 0%
Free Cash Flow	-1.14M▲ 0%	-3.34M▼ 194.1%	-9.42M▼ 181.6%	-2.51M▲ 73.4%	-792.72K▲ 68.4%	-414K▲ 47.8%	-1.57M▼ 279.5%	-2.37M▼ 51.1%	-1.11M▲ 53.4%	2.17M▲ 0%
FCF Margin %	-7.68%	-16.24%	-35.64%	-9.2%	-8.28%	-1.53%	-3.53%	-9.73%	-2.65%	6.09%
FCF Growth %	25.95%	-194.12%	-181.64%	73.38%	68.38%	47.77%	-279.47%	-51.11%	53.37%	3.63%
FCF per Share	-0.09	-0.25	-0.67	-0.15	-0.05	-0.03	-0.09	-0.15	-0.07	-0.07
FCF Conversion (FCF/Net Income)	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x	-0.72x
Interest Paid	0	0	0	0	0	0	2K	0	0	0
Taxes Paid	0	0	0	0	0	0	4.57M	1.44M	2.58M	-1.49M

SRTS Key Ratios

Sensus Healthcare, Inc. (SRTS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
Return on Equity (ROE)	-3.27%	-27.53%	-10.61%	-6.24%	-27.62%	17.34%	65.45%	1%	12.7%	-5.87%
Return on Invested Capital (ROIC)	-4.73%	-39.71%	-16.91%	-8.36%	-42.16%	31.38%	63.04%	-1.14%	19.94%	19.94%
Gross Margin	66.48%	67.03%	63.99%	64.4%	54.81%	62.82%	66.53%	57.61%	58.44%	47.95%
Net Margin	-2.34%	-18.02%	-7.65%	-6.24%	-71.38%	15.23%	54.44%	1.99%	15.9%	-8.44%
Debt / Equity	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x	0.01x
Interest Coverage	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-	-
FCF Conversion	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x	-0.72x
Revenue Growth	44.17%	39%	28.36%	3.16%	-64.87%	182.36%	64.68%	-45.2%	71.31%	-13.79%

SRTS Frequently Asked Questions

Sensus Healthcare, Inc. (SRTS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Sensus Healthcare, Inc. (SRTS) reported $35.6M in revenue for fiscal year 2024. This represents a 513% increase from $5.8M in 2014.

Sensus Healthcare, Inc. (SRTS) grew revenue by 71.3% over the past year. This is strong growth.

Sensus Healthcare, Inc. (SRTS) reported a net loss of $3.0M for fiscal year 2024.

Dividend & Returns

Sensus Healthcare, Inc. (SRTS) has a return on equity (ROE) of 12.7%. This is reasonable for most industries.

Sensus Healthcare, Inc. (SRTS) generated $2.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SRTS

Sensus Healthcare, Inc. (SRTS) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→